If you are seeing this message, you may be experiencing temporary network problems. Please wait a few minutes and refresh the page. If the problem persists, you may wish to report it to your local Network Manager.
It is also possible that your web browser is not configured or not able to display style sheets. In this case, although the visual presentation will be degraded, the site should continue to be functional. We recommend using the latest version of Microsoft or Mozilla web browser to help minimise these problems.
Wiley InterScience | |||||||||
![]() Journal of Veterinary Medicine Series AVolume 54 Issue 4, Pages 203 - 209 Published Online: 18 Apr 2007 2007 The Authors Journal compilation 2007 Blackwell Verlag
Abstract | References | Full Text: HTML, PDF (Size: 527K) | Related Articles | Citation Tracking Plasma Electrophoretogram in Feline Immunodeficiency Virus (FIV) and/or Feline Leukaemia Virus (FeLV) Infections Copyright 2007 The Authors Journal compilation 2007 Blackwell Verlag, Berlin Summary
The electrophoretogram of 89 cats, including those infected by feline immunodeficiency virus (FIV+), feline leukaemia virus (FeLV+) and non-infected, showed statistically significant differences in several of the fractions. FIV+ cats had very high protein values (mean, 8.10 g/dl), mostly because of hypergammaglobulinemia (mean, 2.81 g/dl) as compared with non-infected animals and FeLV+. In addition, in these FIV+ animals, the albumin/globulins ratio (A/G) was very low (mean, 0.72). Statistically significant differences in A/G and α2-globulin fraction were observed in FeLV+ group (A/G mean, 0.88 ± 0.08; α2-globulin, mean, 0.84 ± 0.07 g/dl) when compared with non-infected group (A/G mean, 1.06 ± 0.08; α2-globulin mean, 0.68 ± 0.04 g/dl). The α1-globulin fraction was higher in double infected animals (FIV and FeLV positive, F-F) (3.55 g/dl), than in FeLV+ or FIV+ cats (3.10 and 3.07 g/dl respectively), but no statistical conclusions may be drawn from this fact because of the low number of F-F animals. This technique may help to assess the initial clinical status of retrovirus-infected cats, and the clinical course of these chronic diseases, specifically during and after suitable therapy. With 1 figure and 4 tables Received for publication June 1, 2006 |